Insider · CIK 0001515051
Scott Mendel
director
Files at QTRX (Quanterix Corp), AKYA (Akoya Biosciences, Inc.), QSI (Quantum-Si Inc). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 1, 2026 | QTRX Quanterix Corp | AGrant or award Common Stock | +4,398 | $3.41 | $15k | 28,454 | 10 d ago |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Common Stock | -28,500 | - | - | 0 | Jul 10, 2025 |
| Jul 8, 2025 | QTRX Quanterix Corp | AGrant or award Common Stock | +4,189 | - | - | 4,189 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -35,562 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | QTRX Quanterix Corp | AGrant or award Common Stock | +24,464 | $0.00 | $0 | 28,653 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -30,549 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | QTRX Quanterix Corp | AGrant or award Stock Option (right to buy)derivative | +50,758 | $0.00 | $0 | 50,758 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -56,322 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -44,959 | $0.00 | $0 | 0 | Jul 10, 2025 |
| Jul 8, 2025 | AKYA Akoya Biosciences, Inc. | JOther Stock Option (right to buy)derivative | -50,000 | $0.00 | $0 | 0 | Jul 10, 2025 |
| May 19, 2025 | QSI Quantum-Si Inc | AGrant or award Stock Option (right to buy)derivative | +126,095 | $0.00 | $0 | 126,095 | May 21, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.